Toward a comprehensive functional annotation of the human genome

人类基因组的全面功能注释

基本信息

项目摘要

The goal of the ENCODE Project is to provide the biomedical community with a complete and biologically interpretable annotation of the human genome. This means discovering and mapping all parts of all genes, including exons, introns, promoters and cis-regulatory sequences, in previous phases of the ENCODE Project, the applicants of this proposal developed and applied robust, high-throughput, genome-wide methods for determining transcription factor occupancy, assessing DNA methylation, identifying RNA transcripts, and experimentally testing candidate regulatory elements and mutations. The combination of experiences from the previous phases with the resulting technology and analysis platforms and the existing, highly productive infrastructure of the applicants form the basis of this response to NHGRI's RFA-HG-11-024 ("Expanding the Encyclopedia of DNA Elements (ENCODE) in the Human and Model Organisms"). This application presents an ambitious proposal to expand the biological dimensions of ENCODE to include essentially all transcription factors for measurements of occupancy and to produce transcriptomes from hundreds of very specific cell types, and even single cells. The specific plan is to: 1) determine genome wide occupancy for all transcription factors and major cofactors with high resolution in two or more cell types; 2) map and quantify all messenger RNA transcripts, microRNAs and other non-ribosomal RNAs in more than 300 well-defined, uncultured cell types; 3) map DNA methylation state genome-wide at nucleotide resolution in more than 300 cell types; and 4) apply a high-throughput transient transfection assay system to test the impact of -2,000 candidate regulatory elements on gene regulation. All experimental work in this project will be evaluated by appropriate quality metrics, and after quality control, all data will be rapidly deposited in publi, freely accessible genome databases. In addition, computational analyses, including evaluation of comparative and population genomics data, will be integrated with the experimental production to help ensure quality and to capture information in forms useful to biologists, genomicists, and medical researchers. Completion of these Specific Aims will enable biomedical researchers to better and more rapidly understand the consequences of mutations in genomic disorders, including cancer, cardiovascular disease, and almost ail common diseases and, therefore, to more fully realize the potential of genomics to impact human health.
ENCODE计划的目标是为生物医学界提供完整的、生物学上可解释的人类基因组注释。这意味着发现和绘制所有基因的所有部分,包括外显子,内含子,启动子和顺式调控序列,在ENCODE项目的前几个阶段,本提案的申请人开发并应用了强大的,高通量的全基因组方法来确定转录因子占用,评估DNA甲基化,鉴定RNA转录物,并实验测试候选调控元件和突变。将前一阶段的经验与所产生的技术和分析平台以及申请人现有的高效基础设施相结合,形成了对NHGRI RFA-HG-11-024(“扩展人类和模式生物中的DNA元件百科全书(ENCODE)”)的响应的基础。这个应用程序提出了一个雄心勃勃的建议,即扩展ENCODE的生物学维度,基本上包括所有用于占用测量的转录因子,并从数百种非常特定的细胞类型,甚至单个细胞中产生转录组。具体计划是:1)以高分辨率确定两种或两种以上细胞类型中所有转录因子和主要辅因子的全基因组占用率;2)在300多种明确的、未培养的细胞类型中绘制和量化所有信使RNA转录物、microRNAs和其他非核糖体RNA;3)在300多种细胞类型中以核苷酸分辨率绘制DNA甲基化状态的全基因组图谱;4)应用高通量瞬时转染检测系统检测- 2000个候选调控元件对基因调控的影响。本项目的所有实验工作都将通过适当的质量指标进行评估,在质量控制之后,所有数据将迅速存入公开的、可免费访问的基因组数据库。此外,计算分析,包括对比较和人口基因组数据的评价,将与实验生产结合起来,以帮助确保质量,并以对生物学家、基因组学家和医学研究人员有用的形式获取信息。完成这些具体目标将使生物医学研究人员能够更好、更迅速地了解基因组疾病(包括癌症、心血管疾病和几乎所有常见疾病)突变的后果,从而更充分地认识基因组学影响人类健康的潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard M Myers其他文献

Richard M Myers的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard M Myers', 18)}}的其他基金

Genomic Diagnosis in Children with Developmental Delay
发育迟缓儿童的基因组诊断
  • 批准号:
    8517294
  • 财政年份:
    2013
  • 资助金额:
    $ 348.34万
  • 项目类别:
Toward a comprehensive functional annotation of the human genome
人类基因组的全面功能注释
  • 批准号:
    8709029
  • 财政年份:
    2012
  • 资助金额:
    $ 348.34万
  • 项目类别:
Toward a comprehensive functional annotation of the human genome
人类基因组的全面功能注释
  • 批准号:
    8402461
  • 财政年份:
    2012
  • 资助金额:
    $ 348.34万
  • 项目类别:
Toward a comprehensive functional annotation of the human genome
人类基因组的全面功能注释
  • 批准号:
    8928009
  • 财政年份:
    2012
  • 资助金额:
    $ 348.34万
  • 项目类别:
Toward a comprehensive functional annotation of the human genome
人类基因组的全面功能注释
  • 批准号:
    8548394
  • 财政年份:
    2012
  • 资助金额:
    $ 348.34万
  • 项目类别:
2/2-Whole Genome and Exome Sequencing for Bipolar Disorder
双相情感障碍的 2/2-全基因组和外显子组测序
  • 批准号:
    8668562
  • 财政年份:
    2011
  • 资助金额:
    $ 348.34万
  • 项目类别:
2/2-Whole Genome and Exome Sequencing for Bipolar Disorder
双相情感障碍的 2/2-全基因组和外显子组测序
  • 批准号:
    8326235
  • 财政年份:
    2011
  • 资助金额:
    $ 348.34万
  • 项目类别:
2/2-Whole Genome and Exome Sequencing for Bipolar Disorder
双相情感障碍的 2/2-全基因组和外显子组测序
  • 批准号:
    8206174
  • 财政年份:
    2011
  • 资助金额:
    $ 348.34万
  • 项目类别:
2/2-Whole Genome and Exome Sequencing for Bipolar Disorder
双相情感障碍的 2/2-全基因组和外显子组测序
  • 批准号:
    8495418
  • 财政年份:
    2011
  • 资助金额:
    $ 348.34万
  • 项目类别:
HudsonAlpha Cancer Genome Characterization Center
HudsonAlpha 癌症基因组表征中心
  • 批准号:
    7908244
  • 财政年份:
    2008
  • 资助金额:
    $ 348.34万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 348.34万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 348.34万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 348.34万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 348.34万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 348.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 348.34万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 348.34万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 348.34万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 348.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 348.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了